Effects of empagliflozin according to background angiotensin receptor-neprilysin inhibitor and mineralocorticoid receptor antagonist use in heart failure with reduced ejection fraction (SUGAR-DM-HF)
31 August 2026 (13:15 - 14:00)
Organised by: 
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
6 More presentations in this session
Doctor S. Morrissey (Chapel Hill, US)
Doctor M. Ferreira (Funchal, PT)
Doctor M. Witkowski (Berlin, DE)
Access the full session
The Event
ESC Congress 2026
31 August 2026
13:15 CET
You may be interested in
Congress Session
31 August 2024
Congress Presentation
Congress Presentation
